CDSCO

AstraZeneca India gets dual CDSCO approval for Trastuzumab deruxtecan

Read more

Cipla receives USFDA approval for plazomicin injection in India

Read more

Glenmark partners with Pfizer to launch Abrocitinib in India

Read more

AstraZeneca receives CDSCO approval to import and market Andexanet Alfa in India

Read more

Will 2024 be a year of regulatory renaissance?

Read more

AstraZeneca receives CDSCO approval to market its inhalation aerosol

Read more

Zydus begins Phase II trial of ZYIL1, NLRP3 inhibitor in patients with ALS

Read more

IPA organises eighth Advanced GMP Workshop

Read more

India Pharma Inc in M&A mode once again

Read more

CDSCO and IDMA organise ‘Revision of Schedule-M’ workshop in Mumbai

Read more